BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37369027)

  • 1. Circulating proteome for pulmonary nodule malignancy.
    Khodayari Moez E; Warkentin MT; Brhane Y; Lam S; Field JK; Liu G; Zulueta JJ; Valencia K; Mesa-Guzman M; Nialet AP; Atkar-Khattra S; Davies MPA; Grant B; Murison K; Montuenga LM; Amos CI; Robbins HA; Johansson M; Hung RJ
    J Natl Cancer Inst; 2023 Sep; 115(9):1060-1070. PubMed ID: 37369027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
    Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Patient With a Pulmonary Nodule: A Review.
    Mazzone PJ; Lam L
    JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
    Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
    J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability of cancer in pulmonary nodules detected on first screening CT.
    McWilliams A; Tammemagi MC; Mayo JR; Roberts H; Liu G; Soghrati K; Yasufuku K; Martel S; Laberge F; Gingras M; Atkar-Khattra S; Berg CD; Evans K; Finley R; Yee J; English J; Nasute P; Goffin J; Puksa S; Stewart L; Tsai S; Johnston MR; Manos D; Nicholas G; Goss GD; Seely JM; Amjadi K; Tremblay A; Burrowes P; MacEachern P; Bhatia R; Tsao MS; Lam S
    N Engl J Med; 2013 Sep; 369(10):910-9. PubMed ID: 24004118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
    van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
    Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease-endemic region.
    Henz Concatto N; Watte G; Marchiori E; Irion K; Felicetti JC; Camargo JJ; Hochhegger B
    Eur Radiol; 2016 Sep; 26(9):2915-20. PubMed ID: 26638164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT.
    Venkadesh KV; Setio AAA; Schreuder A; Scholten ET; Chung K; W Wille MM; Saghir Z; van Ginneken B; Prokop M; Jacobs C
    Radiology; 2021 Aug; 300(2):438-447. PubMed ID: 34003056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung nodules: size still matters.
    Larici AR; Farchione A; Franchi P; Ciliberto M; Cicchetti G; Calandriello L; Del Ciello A; Bonomo L
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29263171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.
    Peters AA; Weinheimer O; von Stackelberg O; Kroschke J; Piskorski L; Debic M; Schlamp K; Welzel L; Pohl M; Christe A; Ebner L; Kauczor HU; Heußel CP; Wielpütz MO
    Eur Radiol; 2023 Jun; 33(6):3908-3917. PubMed ID: 36538071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive model for the diagnosis of benign/malignant small pulmonary nodules.
    Chen W; Zhu D; Chen H; Luo J; Fu H
    Medicine (Baltimore); 2020 Apr; 99(15):e19452. PubMed ID: 32282697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
    Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
    Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
    Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
    BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the BRODERS classifier (Benign
    Maldonado F; Varghese C; Rajagopalan S; Duan F; Balar AB; Lakhani DA; Antic SL; Massion PP; Johnson TF; Karwoski RA; Robb RA; Bartholmai BJ; Peikert T
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33303552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances and Clinical Application of Malignant Probability Prediction Models for 
Solitary Pulmonary Nodule].
    Wang Z; Zhao J; Wang M
    Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):660-667. PubMed ID: 34455736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
    Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
    Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can MRI contribute to pulmonary nodule analysis?
    Koo CW; Lu A; Takahashi EA; Simmons CL; Geske JR; Wigle D; Peikert T
    J Magn Reson Imaging; 2019 Jun; 49(7):e256-e264. PubMed ID: 30575193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.